Dry Eye Treatment Devices Market Size, Share & Trends Report

Dry Eye Treatment Devices Market Size, Share & Trends Analysis Report By Technology (MGX, Combination (MGX+IPL)), By End-use (Hospitals, Ophthalmic Clinics), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68039-042-8
Number of Pages: 100
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Dry Eye Treatment Devices Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Broadband Light (BBL)
- Intense Pulsed Light (IPL)
- Meibomian Gland Expression (MGX)
- Combination (MGX+IPL)
Dry Eye Treatment Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Ophthalmic Clinics
- Others
Dry Eye Treatment Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Dry Eye Treatment Devices Market, By Technology
    - Broadband Light (BBL)
    - Intense Pulsed Light (IPL)
    - Meibomian Gland Expression (MGX)
    - Combination (MGX+IPL)
  - North America Dry Eye Treatment Devices Market, By End-use
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - U.S.
    - U.S. Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - U.S. Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Canada
    - Canada Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Canada Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
- Europe
  - Europe Dry Eye Treatment Devices Market, By Technology
    - Broadband Light (BBL)
    - Intense Pulsed Light (IPL)
    - Meibomian Gland Expression (MGX)
    - Combination (MGX+IPL)
  - Europe Dry Eye Treatment Devices Market, By End-use
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - UK
    - UK Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - UK Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Germany
    - Germany Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Germany Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - France
    - France Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - France Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Italy
    - Italy Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Italy Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Spain
    - Spain Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Spain Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Sweden
    - Sweden Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Sweden Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Norway
    - Norway Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Norway Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Denmark
    - Denmark Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Denmark Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
- Asia Pacific
  - Asia Pacific Dry Eye Treatment Devices Market, By Technology
    - Broadband Light (BBL)
    - Intense Pulsed Light (IPL)
    - Meibomian Gland Expression (MGX)
    - Combination (MGX+IPL)
  - Asia Pacific Dry Eye Treatment Devices Market, By End-use
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - China
    - China Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - China Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Japan
    - Japan Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Canada Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - India
    - India Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - India Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Australia
    - Australia Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Australia Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Thailand
    - Thailand Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Thailand Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - South Korea
    - South Korea Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - South Korea Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
- Latin America
  - Latin America Dry Eye Treatment Devices Market, By Technology
    - Broadband Light (BBL)
    - Intense Pulsed Light (IPL)
    - Meibomian Gland Expression (MGX)
    - Combination (MGX+IPL)
  - Latin America Dry Eye Treatment Devices Market, By End-use
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - Brazil
    - Brazil Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Brazil Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Mexico
    - Mexico Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Mexico Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Argentina
    - Argentina Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Argentina Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
- Middle East and Africa
  - Middle East and Africa Dry Eye Treatment Devices Market, By Technology
    - Broadband Light (BBL)
    - Intense Pulsed Light (IPL)
    - Meibomian Gland Expression (MGX)
    - Combination (MGX+IPL)
  - Middle East and Africa Dry Eye Treatment Devices Market, By End-use
    - Hospitals
    - Ophthalmic Clinics
    - Others
  - Saudi Arabia
    - Saudi Arabia Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Saudi Arabia Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - South Africa
    - South Africa Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - South Africa Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - UAE
    - UAE Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - UAE Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others
  - Kuwait
    - Kuwait Dry Eye Treatment Devices Market, By Technology
      - Broadband Light (BBL)
      - Intense Pulsed Light (IPL)
      - Meibomian Gland Expression (MGX)
      - Combination (MGX+IPL)
    - Kuwait Dry Eye Treatment Devices Market, By End-use
      - Hospitals
      - Ophthalmic Clinics
      - Others

Dry Eye Treatment Devices Market Dynamics

Driver: Rising Number Of Contact Lens Wearers

Wearing contact lenses for a long period leads to Contact Lens-induced Dry Eye (CIDE). There are approximately 140 million contact lens users worldwide. As the number of contact lens users has increased, the incidence of CIDE is also expected to increase parallelly. CIDE is reported to be one of the major reasons for people switching back to glasses from contact lens. However, majority patients strongly refrain to switch back to glasses from contact lenses driving the demand for an efficient CIDE treatment option that prevents avoiding the use of contact lens. Thus, growing number of contact lens users globally is anticipated to increase ophthalmic clinic visits for IPL and MGX treatments. However, the development of modern contact lenses with high oxygen permeability and acceptance of daily disposable lenses are anticipated to render its impact on the market growth in the long run.

Driver: Increasing Usage Of Visual Display Terminals

The increasing number of hours spent at the video display terminals such as computers, mobiles, laptops, TVs, and tablets are among the main risk factor for developing dry eyes. Prolonged exposure to VDT results in lower levels of mucin 5AC in the tears. Mucin 5AC is a protein responsible to retain water on the ocular surface. Therefore, low level of the protein can elevate the signs and symptoms of dry eyes. As digital technology is being adopted on a large scale in everyday life and across all activities, the amount of time spent on VDT by people has increased significantly. Dry eye syndrome due to long exposure to VDT is more common in adults and the younger population compared to old people; as the younger population is more tech-savvy and gets easily addicted to online games, web series. Therefore, the increasing usage of VDT globally is anticipated to boost the prevalence of evaporative dry eye syndrome, thereby fueling the market growth.

Restraint: Presence Of Several Contraindications Pertaining To Intense Pulsed Light (IPL)

Although IPL is effective and safe in treating the root cause of evaporative dry eye disease, it has several contraindications associated with it that limits its adoption. For instance, IPL treatments cannot be performed on patients with a darker skin tone. As it may cause pigment changes due to increased melanin found in their skin. The IPL treatment is also contraindicated in pregnant women, patients with an active infection, compromised immune system, history of sun allergy, cardiac pacemakers, diabetes, and others. Whereas diabetes is one of the leading risk factors for dry eyes and is being contraindicated. Thereby, a consent form is duly filled by the patient each time before a therapy session, which delays the delivery of therapeutic services. Besides, the IPL treatment is applied from tragus to tragus to the lower eyelid. While the upper eyelid is spared from light being covered by the eye pads. However, it is clinically important to treat upper eyelids too.

What Does This Report Include?

This section will provide insights into the contents included in this dry eye treatment devices market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Dry eye treatment devices market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Dry eye treatment devices market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.